Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Hofbauer

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Drug Research|November 5, 2015
From Bone Cell Biology to Novel Therapies of OsteoporosisL C Hofbauer
Annales D'Endocrinologie|April 28, 2006
Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG)L C Hofbauer
European Journal of Endocrinology|September 4, 1999
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolismL C Hofbauer
Lancet (London, England)|August 11, 2001
Osteoprotegerin: a link between osteoporosis and arterial calcification?L C Hofbauer, M Schoppet
European Journal of Endocrinology|March 31, 1999
Androgen effects on bone metabolism: recent progress and controversiesL C Hofbauer, S Khosla
Zeitschrift Fur Gastroenterologie|October 14, 2000
[Transforming growth factor beta as a protective factor in autoimmune pancreatitis]L C Hofbauer, B Simon
European Journal of Endocrinology|November 27, 2001
Serum measurement of osteoprotegerin--clinical relevance and potential applicationsL C Hofbauer, M Schoppet
Deutsche Medizinische Wochenschrift (1946)|November 24, 2011
[Innovations in the treatment of osteoporosis]E Tsourdi, L C Hofbauer
Arthritis and Rheumatism|March 7, 2001
The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritisL C Hofbauer, A E Heufelder
European Journal of Endocrinology|April 1, 1996
Endocrinology meets immunology: T lymphocytes as novel targets for melatoninL C Hofbauer, A E Heufelder
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Drug Research|November 5, 2015
From Bone Cell Biology to Novel Therapies of OsteoporosisL C Hofbauer
Annales D'Endocrinologie|April 28, 2006
Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG)L C Hofbauer
European Journal of Endocrinology|September 4, 1999
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolismL C Hofbauer
Lancet (London, England)|August 11, 2001
Osteoprotegerin: a link between osteoporosis and arterial calcification?L C Hofbauer, M Schoppet
European Journal of Endocrinology|March 31, 1999
Androgen effects on bone metabolism: recent progress and controversiesL C Hofbauer, S Khosla
Zeitschrift Fur Gastroenterologie|October 14, 2000
[Transforming growth factor beta as a protective factor in autoimmune pancreatitis]L C Hofbauer, B Simon
European Journal of Endocrinology|November 27, 2001
Serum measurement of osteoprotegerin--clinical relevance and potential applicationsL C Hofbauer, M Schoppet
Deutsche Medizinische Wochenschrift (1946)|November 24, 2011
[Innovations in the treatment of osteoporosis]E Tsourdi, L C Hofbauer
Arthritis and Rheumatism|March 7, 2001
The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritisL C Hofbauer, A E Heufelder
European Journal of Endocrinology|April 1, 1996
Endocrinology meets immunology: T lymphocytes as novel targets for melatoninL C Hofbauer, A E Heufelder
Pageof 12